Besides its effects similar to those of insulin and metformin in glycemic control and in reducing need for insulin, 6-month sitagliptin therapy may also associated with improvement of cognitive function in elderly DM patients with and without AD. The gene discussed is INS; the disease is diabetes mellitus.